ADDIS ABABA, ETHIOPIA / ACCESSWIRE / June 21, 2022 / A year ago, the Mastercard Foundation and Africa CDC (www.AfricaCDC.org)…
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"),…
VoiceFriend broadens its best-of-breed communication and engagement solutions NEWTON, Mass.--(BUSINESS WIRE)--VoiceFriend, provider of the leading HIPAA-compliant, cloud-based communication platform for…
Company’s new solution enhancements enable providers to improve care coordination and collaboration through their patients’ post-acute care journey BALTIMORE--(BUSINESS WIRE)--#ACOs--Real…
Assets include issued patents, patent applications, products, clinical trial results, licensing agreementsApplied Biology generated approximately $8 million in revenues and…
Canalevia®-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for chemotherapy-induced…
Additional analyses to determine if a subgroup of patients and/or symptoms may have been responsive to treatmentCompany remains on track…
JACKSON CENTER, PA / ACCESSWIRE / June 21, 2022 / Recognizing the breadth of application of its patented extracorporeal treatment…
REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…
FLORHAM PARK, NJ / ACCESSWIRE / June 21, 2022 / Hisamitsu America, a subsidiary of Hisamitsu Pharmaceutical Co., Inc., and…